Cover image of the article: Cost-Benefit Analysis of the Neonatal Screening Program Implementation for Congenital Hypothyroidism in I. R. Iran

Image Credit:Int J Endocrinol Metab

Cost-Benefit Analysis of the Neonatal Screening Program Implementation for Congenital Hypothyroidism in I. R. Iran

Authors

AR Delavari1,*, SH Yarahmadi2, R Birjandi2, AR Mahdavi2, A Norouzi Nejad2, M Dini3
1Disease Control Center, Ministry of Health and Medical Education, delavari@yahoo.com, IR.Iran
2Disease Control Center, Ministry of Health and Medical Education, IR.Iran
*Corresponding Author: Disease Control Center, Ministry of Health and Medical Education, delavari@yahoo.com, IR.Iran. Email: delavari@yahoo.com

International Journal of Endocrinology and Metabolism:Vol. 4, issue 2; 84-87
Published online:Apr 30, 2006
Article type:Research Article
Received:Feb 01, 2005
Accepted:Dec 14, 2005
How to Cite:Delavari A, Yarahmadi S, Birjandi R, Mahdavi A, Norouzi Nejad A, et al. Cost-Benefit Analysis of the Neonatal Screening Program Implementation for Congenital Hypothyroidism in I. R. Iran. Int J Endocrinol Metab. 2006;4(2):. doi:

Abstract

Congenital Hypothyroidism (CH) is one of the most preventable causes of mental retardation and can be detected through neonatal screening; it is estimated 1200 CH patients are born in Iran, annually. The aim of this investigation was to provide a report on the outcome and estimate the cost-benefit ratio of the screening program im-plementation for CH in Iran based on the pilot study. Materials and Methods: The cost of the screen-ing program for CH for each newborn was based on data gathered from the pilot study of three provinces and the amount then multiplied by the number of births per year. The care cost of men-tally retarded individuals is calculated based on the Welfare budget of caring for these people. Results: Total cost of implementation of the neonatal screening program for CH during the first year is 16, 256, 400, 000 Rials ($ 2, 000, 000). The ratio of the cost of care for the children to the cost of implementation of the screening pro-gram is about 1 to 16 and the ratio of the benefit (cost saving) to the implementation cost is 1 to 15. Conclusion: The neonatal screening program for CH has a very high potential for implementation in the country. As a result, the implementation of the CH screening program as the first screen-ing of newborns provides a basis for better un-derstanding and timely detection of CH and other metabolic diseases in Iran.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Jan
2009
Cost–Benefit and Effectiveness of Newborn Screening of Congenital Hypothyroidism: Findings from a National Program in Iran

Cost–Benefit and Effectiveness of Newborn Screening of Congenital Hypothyroidism: Findings from a National Program in Iran

SH Yarahmadi,
SJ Tabibi,
KH Alimohammadzadeh,
E Ainy,
MM Gooya,
M Mojarrad
,et al.

Yarahmadi S, Tabibi S, Alimohammadzadeh K, Ainy E, Gooya M, et al. Cost–Benefit and Effectiveness of Newborn Screening of Congenital Hypothyroidism: Findings from a National Program in Iran. Int J Endocrinol Metab. 2010;8(1):e94632. doi:

28
Jan
2016
Cost-Utility of Screening Program for Neonatal Hypothyroidism in Iran

Cost-Utility of Screening Program for Neonatal Hypothyroidism in Iran

Nahid Hatam,
Mehrdad Askarian,
Peivand Bastani,
Kimia Pourmohammadi,
Samad Shirvani

Hatam N, Askarian M, Bastani P, Pourmohammadi K, Shirvani S. Cost-Utility of Screening Program for Neonatal Hypothyroidism in Iran. Shiraz E-Med J. 2016;17(1):e33606. doi: https://doi.org/10.17795/semj33606

27
Apr
2020
A Success Story: Review of the Implementation and Achievements of the National Newborn Screening Program for Congenital Hypothyroidism in Iran

A Success Story: Review of the Implementation and Achievements of the National Newborn Screening Program for Congenital Hypothyroidism in Iran

Shahin Yarahmadi,
Nasrin Azhang,
Bahram Nikkhoo,
Khaled Rahmani

Yarahmadi S, Azhang N, Nikkhoo B, Rahmani K. A Success Story: Review of the Implementation and Achievements of the National Newborn Screening Program for Congenital Hypothyroidism in Iran. Int J Endocrinol Metab. 2020;18(2):e99099. doi: https://doi.org/10.5812/ijem.99099

8
May
2014
What Has National Screening Program Changed in Cases with Congenital Hypothyroidism?

What Has National Screening Program Changed in Cases with Congenital Hypothyroidism?

Şebnem Özgelen Özgelen,
Veysel Nijat Baş,
Semra Çetinkaya,
Zehra Aycan

Özgelen ŞÖ, Nijat Baş V, Çetinkaya S, Aycan Z. What Has National Screening Program Changed in Cases with Congenital Hypothyroidism?. Inn J Pediatr. 2014;24(3):. doi:

12
Jun
2013
Cost-Utility Analysis of Neonatal Screening Program, Shiraz University of Medical Sciences, Shiraz, Iran, 2010

Cost-Utility Analysis of Neonatal Screening Program, Shiraz University of Medical Sciences, Shiraz, Iran, 2010

Mehrdad Askarian,
Nahid Hatam,
Samad Shirvani,
Mehdi Javanbakht,
Mohsen Rastegar

Askarian M, Hatam N, Shirvani S, Javanbakht M, Rastegar M. Cost-Utility Analysis of Neonatal Screening Program, Shiraz University of Medical Sciences, Shiraz, Iran, 2010. Inn J Pediatr. 2013;23(5):. doi:

More by these authors

AR DelavariPubMedScholar
SH YarahmadiPubMedScholar
R BirjandiPubMedScholar
AR MahdaviPubMedScholar
A Norouzi NejadPubMedScholar
Share
Cited by
Metrics